文献速递产科母胎医学生殖医学

Asherman综合征对母儿发病率的影响及受孕方式评估

Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method.
PubMed 文献 · J Minim Invasive Gynecol · 2020-10-14

回顾性队列研究分析43例既往接受宫腔镜粘连分离术的Asherman综合征患者单胎妊娠,评估母儿结局及受孕方式差异。结果显示子痫前期、胎盘植入谱系疾病、产后出血及新生儿畸形发生率较高,但体外受精与非体外受精组间无显著差异。

要点

  • Asherman综合征妊娠早产率11.6%,胎盘植入谱系疾病14.0%,产后出血32.6%。
  • 新生儿任何原因解剖畸形发生率18.6%,胎儿生长受限9.3%。
  • 体外受精与非体外受精组的母儿结局无显著差异。

核心结论

  • Asherman综合征妊娠的胎儿生长受限、胎盘植入谱系疾病、产后出血及新生儿解剖畸形发生率高于一般人群。
  • 接受宫腔镜粘连分离术后,体外受精与非体外受精受孕者的母儿结局无显著差异。

研究设计与样本

  • 回顾性队列研究,纳入40例既往在本机构接受宫腔镜粘连分离术的Asherman综合征患者,共43例单胎分娩。
  • 按March分类:轻度20例(50%),中度18例(45%),重度2例(5%)。
  • 43例单胎中,非体外受精受孕27例(62.8%),体外受精受孕16例(37.2%)。

主要发现

  • 总体早产率11.6%,两种受孕方式组间无差异。
  • 胎儿生长受限发生率9.3%,组间无差异。
  • 胎盘植入谱系疾病发生率14.0%,产后出血发生率32.6%,组间无差异。
  • 新生儿任何原因解剖畸形发生率18.6%,组间无差异。

关键数值与推荐

  • 主要结局包括妊娠期高血压疾病、妊娠期糖尿病、胎膜早破、产后出血及胎盘植入谱系疾病。
  • 次要结局包括出生孕周、分娩方式、体重、身长、1分钟和5分钟Apgar评分、氧需求、解剖畸形及新生儿住院时长。

临床怎么用

  • 对Asherman综合征治疗后的妊娠应加强母儿监测,警惕胎儿生长受限、胎盘植入谱系疾病、产后出血及新生儿畸形。
  • 受孕方式(体外受精与非体外受精)不显著影响治疗后Asherman综合征患者的母儿结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: Create a comprehensive summary of maternal and neonatal morbidities from patients previously treated for Asherman syndrome and evaluate for differences in perinatal outcomes based on conception method. DESIGN: Retrospective cohort. SETTING: Community teaching hospital affiliated with a large academic medical center. PATIENTS: Total of 43 singleton births identified from 40 patients previously treated at our institution for Asherman syndrome. INTERVENTIONS: Review of fertility and obstetric data to summarize the maternal and neonatal outcomes in singleton births from patients with Asherman syndrome who had been treated with hysteroscopic adhesiolysis. MEASUREMENTS AND MAIN RESULTS: Primary outcomes of maternal morbidity (i.e., hypertensive disease, gestational diabetes, ruptured membranes, postpartum hemorrhage, morbidly adherent placenta [MAP]) and secondary outcomes of neonatal morbidity (i.e., gestational age at birth, method of delivery, weight, length, 1- and 5-minute Apgar score oxygen requirement, anatomic malformations, length of neonatal admission) were evaluated. We identified 40 patients who completed successful treatment of Asherman syndrome and went on to carry a singleton gestation within our institution: 20 (50%) with mild disease, 18 (45%) with moderate disease, and 2 (5%) with severe disease under the March classification system. In total, 43 singleton births were examined, with 27 of 43 (62.8%) conceived without in vitro fertilization (IVF) (group A: non-IVF conception) and 16 of 43 (37.2%) conceived through IVF (group B: IVF conception). The overall rate of preterm birth in Asherman pregnancies was 11.6%, with no difference between the 2 conception groups. We documented 9.3% cases with intrauterine growth restriction, with no difference based on conception groups. The rate of MAP in patients with Asherman syndrome was 14.0%, and the rate of postpartum hemorrhage was 32.6%, with no differences between the conception groups. Newborn anatomic malformations of any cause were documented in 18.6% of all singleton births, with no difference between the conception groups. CONCLUSION: Our series indicates a higher incidence of intrauterine growth restriction, MAP, postpartum hemorrhage, and newborn anatomic malformations in Asherman syndrome pregnancies than that reported in pregnancies within the general population. However, we found no significant differences in the maternal and neonatal outcomes of patients with Asherman syndrome who conceived with or without IVF after being treated with hysteroscopic adhesiolysis.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Wang J, Movilla P, Morales B, et al. Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method. J Minim Invasive Gynecol. 2020. PMID: 33065259. doi:10.1016/j.jmig.2020.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。